BK virus-specific immunity kinetics: a predictor of recovery from polyomavirus BK-associated nephropathy
- PMID: 21831150
- DOI: 10.1111/j.1600-6143.2011.03693.x
BK virus-specific immunity kinetics: a predictor of recovery from polyomavirus BK-associated nephropathy
Abstract
Impaired BKV-specific immunity is associated with development of BKV-associated nephropathy. Suitable immunological parameters to identify patients at risk, however, are still debated. We monitored 18 kidney-transplant recipients through the course of self-limited BKV-reactivation (n = 11) and BKV-associated nephropathy (n = 7). BKV-specific cellular immunity directed to nonstructural small and Large T-antigen, and structural VP1-3 was analyzed in an interferon-γ Elispot assay. BKV-specific IgM and IgG were measured using an enzyme-linked immunosorbent assay simultaneously. BKV-specific cellular immunity directed to five BKV-proteins increased significantly from diagnosis to resolution of BKV-reactivation (p < 0.001). Patients with self-limited BKV-reactivation developed BKV-specific T cells without therapeutic interventions, and cleared BKV-reactivation within a median period of 1 month. Patients with BKV-associated nephropathy, however, showed BKV-specific T cells after a median period of 5 months after therapeutic interventions only, and cleared BKV-reactivation after a median period of 8 months. Anti-structural T cells were detected earlier than anti-nonstructural T cells, which coincided with BKV-clearance. Patients with BKV-associated nephropathy showed the highest frequencies of BKV-specific T cells at recovery, the highest increase in BKV-specific IgG and persistence of increased IgM levels (p < 0.05). Our results suggest prognostic values of BKV-specific immune monitoring to identify those patients at risk of BKV-associated nephropathy and to aid in the management of therapeutic interventions.
©2011 The Authors Journal compilation © 2011 The American Society of Transplantation and the American Society of Transplant Surgeons.
Similar articles
-
Human polyomavirus type 1 (BK virus) agnoprotein is abundantly expressed but immunologically ignored.Clin Vaccine Immunol. 2007 Aug;14(8):959-68. doi: 10.1128/CVI.00123-07. Epub 2007 May 30. Clin Vaccine Immunol. 2007. PMID: 17538118 Free PMC article.
-
Polyomavirus BK-specific cellular immune response to VP1 and large T-antigen in kidney transplant recipients.Am J Transplant. 2007 May;7(5):1131-9. doi: 10.1111/j.1600-6143.2007.01754.x. Epub 2007 Mar 12. Am J Transplant. 2007. PMID: 17359507
-
BK-VP3 as a new target of cellular immunity in BK virus infection.Transplantation. 2011 Jan 15;91(1):100-7. doi: 10.1097/tp.0b013e3181fe1335. Transplantation. 2011. PMID: 21452414
-
BK polyomavirus infection and nephropathy: the virus-immune system interplay.Nat Rev Nephrol. 2011 May 24;7(7):399-406. doi: 10.1038/nrneph.2011.59. Nat Rev Nephrol. 2011. PMID: 21610680 Review.
-
Cellular immune responses to BK virus.Curr Opin Organ Transplant. 2008 Dec;13(6):569-74. doi: 10.1097/MOT.0b013e3283186b93. Curr Opin Organ Transplant. 2008. PMID: 19060544 Review.
Cited by
-
Phenotypic and functional characterization of circulating polyomavirus BK VP1-specific CD8+ T cells in healthy adults.J Virol. 2013 Sep;87(18):10263-72. doi: 10.1128/JVI.01540-13. Epub 2013 Jul 17. J Virol. 2013. PMID: 23864628 Free PMC article.
-
Pretransplant BK Virus-Specific T-Cell-Mediated Immunity and Serotype Specific Antibodies May Have Utility in Identifying Patients at Risk of BK Virus-Associated Haemorrhagic Cystitis after Allogeneic HSCT.Vaccines (Basel). 2021 Oct 22;9(11):1226. doi: 10.3390/vaccines9111226. Vaccines (Basel). 2021. PMID: 34835157 Free PMC article.
-
Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients.PLoS Pathog. 2012;8(4):e1002650. doi: 10.1371/journal.ppat.1002650. Epub 2012 Apr 12. PLoS Pathog. 2012. PMID: 22511874 Free PMC article. Clinical Trial.
-
The impact of donor viral replication at transplant on recipient infections posttransplant: a prospective study.Transplantation. 2015 Mar;99(3):602-8. doi: 10.1097/TP.0000000000000354. Transplantation. 2015. PMID: 25148381 Free PMC article.
-
Dynamics of virus-specific T cell immunity in pediatric liver transplant recipients.Am J Transplant. 2018 Sep;18(9):2238-2249. doi: 10.1111/ajt.14967. Epub 2018 Jul 10. Am J Transplant. 2018. PMID: 29900673 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous